Lumida
/HURN
⌘K
Huron Consulting Group Inc

Huron Consulting Group Inc

HURN
$114.80USD-3.33%-3.96 today

MARKET CAP

1.9B

P/E (TTM)

14.6x

FWD P/E

12.0x

DAY RANGE

$114 – $122

52W RANGE

$85
$187

AI Summary

Stalk
Buy NowMedium

HURN remains in a Stage 2 advancing phase supported by a Lockout Rally, with price accepted above rising EMAs and the 50 DMA while volume expands on advances. The medium-term bias is bullish, and despite short-term extension, institutional demand dynamics justify participation. We favor buying now at the current breakout to ride further continuation.

  • Q1 2026 revenue before reimbursables $443.7M, +12.1% YoY
  • Adjusted EBITDA margin 11.4% of RBR; 2026 RBR guidance $1.78–1.86B with 14.5–15% margin
  • Net income margin fell to 5.1% in Q1 2026 from 6.1% in Q1 2025
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Huron Consulting Group (NASDAQ: HURN) is a prominent consulting firm specializing in healthcare, education, and commercial services. The company offers a range of strategic and operational advisory solutions to help organizations optimize operations and navigate complexities in regulatory environments, particularly focusing on performance improvement and digital transformation with an increasing integration of advanced technologies like AI. Huron is well-positioned within its sectors, benefiting from strong relationships with clients who face increasing financial pressures and regulatory scrutiny, thus enhancing its relevance in the ongoing shift towards technology-driven consulting.

Bull says

  • Q1 2026 revenue before reimbursables $443.7M, +12.1% YoY
  • Adjusted EBITDA margin 11.4% of RBR; 2026 RBR guidance $1.78–1.86B with 14.5–15% margin
  • $155.5M share repurchase (6.5% of shares) underscores capital return focus
  • Expanding AI integration pipeline likely to drive growth and margin gains
  • High earnings yield and strong growth factor support attractive valuation
  • Sensitivity to rising rates and low leverage profile add upside potential

Bear says

  • Net income margin fell to 5.1% in Q1 2026 from 6.1% in Q1 2025
  • Operational costs rose faster than revenue, pressuring profitability
  • Potential Medicaid funding cuts and regulatory changes may reduce client spend
  • Negative analyst revisions and elevated short interest signal investor skepticism
  • Client financial strain could delay or reduce consulting engagements
  • Limited scale benefits and modest dividend yield may deter income investors

Investment themes with HURN

Others +0.32%

Miscellaneous or uncategorized companies

ATAI · SVIX · SVXY

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-09-2026bullish

Transcript signals

Bull points

  • First quarter of 2026 produced RBR of $443.7 million, up 12.1% from $395.7 million in the same quarter of 2025, driven by growth across all three operating segments.
  • 21.6% for Q1 2026 compared to 18.8% in the same quarter in 2025, primarily driven by decreases in compensation costs for our revenue-generating professionals, practice, administration, and meeting expenses.
  • 22.3% over the prior year period, hosting RBR of $91 million for Q1 2026, compared to $74.5 million in the first quarter of 2025.

Bear points

  • This was a $343 million increase in net debt compared to Q4 2025, primarily due to our annual cash bonus payment and share repurchases during the quarter.
Read full transcript analysis ›